Hello everyone,

the position $BATS (+0.43%) will probably reach its peak soon. I had thought about possibly switching to leveraged S&P500 or Allworld 🤔.

However, my personal div. return is already above 10%. That's really strong and makes it difficult argh 😩.

Hello Community,

Today I'd like to discuss my somewhat confusing use of various brokers. Maybe one or the other can give me some support here.

Consorsbank

I started investing a few years ago when I was still living in Germany. I used a well-known but rather expensive broker ( #consorsbank ). ETF savings plans are partly free here and I use the $XDWD (-0.55%) (TER 0.19%) as well as the $XMAW (-0.66%) (TER 0.25%). These 2 ETFs are deliberately separated, as the latter is backed by another cash inflow, the increase in value of which I would like to view separately (rent of a paid-off rental apartment).

However, historically, one-off purchases (order costs: 10 Euro + 0.25%) and savings plans (order costs: 1.5%) some individual positions such as $GOOGL (+1.9%) , $MC (-2.64%) , $META (+0.53%) , $SHEL (-0.69%) , $BATS (+0.43%) , $INTC (-3.64%) or $ASML (+0.42%) . So a colorful portfolio without focus (e.g. growth or dividends only, USA only or other).

Current account is required at Consorsbank and therefore not closed, custody account not absolutely necessary.

SaxoBank

I moved to Switzerland almost 4 years ago and initially invested here via DeGiro, but due to the cost reduction I switched to SaxoBank and actually closed DeGiro completely. Order fees of 1$ + 0.08% for American shares. European ones are usually 3 Euro + 0.08%. However, the stamp duty which applies to all brokers in Switzerland (0.075 Swiss stock exchange, 0.15% foreign stock exchange).

ETFs continued to be saved via Consorsbank. Individual shares (apart from a few small savings plans) from now on with SaxoBank. This applies to both new and existing positions ($GOOGL (+1.9%) , $INTC (-3.64%) , $MSFT (-0.04%) , $AMD (-1.66%) , $NESN (-0.88%) or $NOVO B (-0.43%) )

No trading with fractional shares possible! Complete transfer from Consorsbank to SaxoBank therefore not possible!

InteractiveBroker

Via Getquin, as well as via a mentioned Reddit group for Swiss finance, I came across the possibility to invest very cost-efficiently with #ibkr which specifically offers the possibility to invest in American ETFs (e.g. $VT (-0.37%) or $VOO (-0.14%) ), which are not only significantly cheaper (TER 0.07%, or 0.03%), but are also tax-exempt due to a tax treaty between #usa and the #schweiz bring tax advantages.

The order fees are incredibly low (0.0035 USD per share) and, as it is not a Swiss broker, there is no stamp duty! Accordingly, another 0.15% (0.075 for Swiss stock exchange) less compared to SaxoBank! Another strong argument is that I can transfer money free of charge from my German bank #euro as well as from my Swiss bank #chf free of charge. However, I would not like to put everything on one card/broker. I haven't invested in IBKR yet, but I'm wondering how I should best divide up my brokers.

Trading with fractional shares is possible and therefore also a portfolio transfer from Consorsbank.

Quick side info:

My wife has her own account with Consorsbank (before moving to Switzerland) and #degiro her own custody account, which doesn't make it any less complicated.

Summary:

Consorsbank:

ETFs plus shares available, high fees for shares, fractional shares possible, based in Germany

SaxoBank:

Shares available, low fees but stamp duty, no fractions of shares, domiciled in Switzerland

IBKR:

nothing available yet, very low fees, no stamp duty, deposit Euro & CHF possible, American ETFs like $VT (-0.37%) fractional shares possible, domicile in the USA (or UK for Swiss investors).

Questions:

a.) In future ETF, e.g. $VT (-0.37%) with IBKR?

a2.) If yes, liquidate existing ETFs and reinvest in American ETFs?

b.) Transfer portfolio, especially Consorsbank?

b2.) If yes, how to divide between SaxoBank and IBKR? Only IBKR?

c.) Are there major risks with IBKR (based in the USA/UK?)

I've already started to shift my portfolio more towards dividends with a stock like $FRO (-0.48%) more in the direction of dividends. I'm in my mid-50s, so you have to think about the future ("Die Rende sin' sischa").

Two new stocks have been added to the portfolio today: $BATS (+0.43%) and $FSK (+1.53%) . Out went $WAF (-0.09%) (-13 percent) and $AAPL (+0.87%) (+13 percent or so).

I am raising my personal price target for dividends in 2025 to EUR 15,000 gross; I want to be much more aggressive than before.

$BATS (+0.43%) has broken out beautifully today, with a run back to the zone you can take the trade. https://www.tradingview.com/x/z3rRyfl7

Enclosed daily and weekly chart

There is also good news today... One of my favorite dividend stocks $BATS (+0.43%) reached a new 52-week high and is currently keeping my portfolio value stable.

The price target for BAT the UBS from 3000 to 3900 pence. The tobacco company's shares are analyst Faham Baig's top favorite. He expects Velo Nicotine Pouches (tobacco-free nicotine pouches) to accelerate sales growth in the New Categories segment, he wrote in his recommendation published on Monday. This would enable the company to achieve its targets for the 2025/26 financial year. He also referred to the strong US dollar for his new price target and rolled the valuation basis further into the future.

Source: finanzen.net

Nevertheless, I am very sad about the developments in this forum. I would like to see more love, respect and solidarity. Instead this forum is becoming more and more a stage for self-promotion, it's just generally going in a nasty, individualistic, envious and selfish direction and so much hatefule interactions.

I'm so sad about it 🥺 and miss the good old days here.

As soon as the $BATS (+0.43%) dividend arrives I'll grab a bunch of flowers and a piece of cake with cream to comfort myself 🥹

Love love love

The Food and Drug Administration (FDA) is backing away from its previously proposed tobacco product standard to ban menthol as a characterizing flavor in cigarettes on public health grounds. The FDA argued that menthol increases the appeal of cigarettes, especially to younger audiences. The proposed ban was intended to reduce experimentation and use among youth while improving the health of current menthol cigarette smokers by encouraging smoking cessation.

The withdrawal of this proposal is seen as a positive for tobacco companies who would have faced the loss of a significant market share. In the United States, there are over 18.5 million smokers aged 12 and older who use menthol cigarettes.

The FDA action aimed to address the leading preventable cause of death and disease in the country and reduce tobacco-related deaths and illnesses associated with menthol cigarette use. The agency also hoped to improve health equity by reducing tobacco-related health disparities.

With the proposal now off the table, tobacco companies are likely to be able to continue selling menthol cigarettes without the threat of an imminent ban. This is reflected in the positive share price performance. The market reaction indicates investor relief as a significant regulatory risk for these companies has been removed.

The news is particularly relevant for British American Tobacco $BATS (+0.43%)which, along with its industry peers $MO (+1.65%)
$PM (+0.34%)
$IMB (+0.75%) may now be able to avoid the financial impact that a menthol ban would have had on sales and market share.

I am still looking for a dividend share and am wavering between $RIO (+0.51%) and $BATS (+0.43%) . Which one do you prefer, so I would like to add both to my portfolio in the future anyway, but which one do you think is better at the current prices?

Hello everyone,

I thought it was time to share my portfolio again and face your criticism👀.

Income: ~900€ net

I save an average of ~€200 per month with special payments and started investing when I started my training: 01.08.23

Brief explanation:

Deka Fond: These are capital-forming benefits (13€ AG / 27€ AN per month)

Had to take an active fund here

Core (planned; distribution not quite right yet)

70% ACWI $ISAC (-0.66%)

10% AI & Big Data

10% India $FLXI (+0.97%)

10% Small Caps

Satellites:

Blackrock 👑 $BLK (+0.7%)

• best performance - simply an awesome company

Monster 🧃 $MNST (-0.91%)

• I am wavering here with the sale / sales are weakening

Realty Income 🏡 $O (+0.72%)

• Can't be missing as a real estate azubi of course

Novo Nordisk 💉 $NOVO B (-0.43%)

• My latest purchase and correspondingly poor performance.

ASML 🔬 $ASML (+0.42%)

• I see great future potential here, growth

LVMH 👜 $MC (-2.64%)

BAT 🚬 $BATS (+0.43%)

Looking back, I'm satisfied with the return so far, knowing that the ACWI alone would probably have performed better on its own. Especially in the first few months, I learned the hard way and tried things out a bit. A few individual stocks are part of the fun, which increases interest in investing in general.

Goals for 2025:

Expand the core, especially the ACWI

Bring individual stocks to €200